Expect Buzz About Rebyota Fecal Product for C. diff
March 2023
New Rx Rebyota will be the first FDA-approved fecal microbiota product for preventing C. difficile recurrence in adults.
It seems unappealing, but a fecal transplant can help restore a healthy GI flora...or “microbiota.”
Save fecal transplants for a patient who has 3 or more C. diff episodes despite treatment...or possibly for any case of severe, refractory C. diff when antibiotics don’t work at all.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote